Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Chubb
US Department of Justice
Healthtrust
Teva
AstraZeneca
Baxter
Fish and Richardson
Accenture

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021829

« Back to Dashboard

NDA 021829 describes NEUPRO, which is a drug marketed by Ucb Inc and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug and one Paragraph IV challenge. Additional details are available on the NEUPRO profile page.

The generic ingredient in NEUPRO is rotigotine. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the rotigotine profile page.
Summary for 021829
Tradename:NEUPRO
Applicant:Ucb Inc
Ingredient:rotigotine
Patents:7
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 021829
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NEUPRO rotigotine FILM, EXTENDED RELEASE;TRANSDERMAL 021829 NDA UCB, Inc. 50474-801 N 50474-801-17
NEUPRO rotigotine FILM, EXTENDED RELEASE;TRANSDERMAL 021829 NDA UCB, Inc. 50474-801 N 50474-801-03

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength2MG/24HR
Approval Date:May 9, 2007TE:RLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Nov 27, 2020Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Mar 30, 2021Product Flag?YSubstance Flag?Delist Request?
Patent:➤ Try a Free TrialPatent Expiration:Mar 18, 2019Product Flag?YSubstance Flag?Delist Request?

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Chinese Patent Office
Argus Health
Federal Trade Commission
Baxter
Cantor Fitzgerald
US Army
Julphar
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.